
Kovai Medical Center (KOVAI) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
3.7B
Gross Profit
2.2B
59.56%
Operating Income
798.8M
21.38%
Net Income
572.3M
15.32%
EPS (Diluted)
₹52.30
Balance Sheet Metrics
Total Assets
18.0B
Total Liabilities
7.1B
Shareholders Equity
10.9B
Debt to Equity
0.66
Cash Flow Metrics
Revenue & Profitability Trend
Kovai Medical Center Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 12.9B | 11.3B | 9.6B | 9.0B | 6.7B |
Cost of Goods Sold | 5.9B | 5.3B | 4.6B | 2.6B | 2.1B |
Gross Profit | 7.0B | 6.1B | 5.0B | 6.5B | 4.6B |
Gross Margin % | 54.1% | 53.4% | 52.2% | 71.7% | 68.8% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | 122.2M | 115.4M | 94.2M | 1.4B | 1.1B |
Other Operating Expenses | 1.2B | 1.1B | 976.8M | 2.4B | 590.0M |
Total Operating Expenses | 1.4B | 1.2B | 1.1B | 3.8B | 1.7B |
Operating Income | 2.9B | 1.7B | 1.2B | 1.7B | 1.3B |
Operating Margin % | 22.6% | 14.9% | 13.0% | 19.0% | 18.8% |
Non-Operating Items | |||||
Interest Income | 183.1M | 161.1M | 99.2M | 87.9M | 76.6M |
Interest Expense | 326.7M | 327.8M | 399.7M | 432.3M | 307.0M |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 2.8B | 2.4B | 1.6B | 1.4B | 1.1B |
Income Tax | 686.1M | 578.3M | 394.5M | 364.2M | 280.5M |
Effective Tax Rate % | 24.7% | 24.3% | 25.4% | 25.9% | 26.5% |
Net Income | 2.1B | 1.8B | 1.2B | 1.0B | 776.9M |
Net Margin % | 16.2% | 15.9% | 12.1% | 11.5% | 11.6% |
Key Metrics | |||||
EBITDA | 4.1B | 3.6B | 2.9B | 2.7B | 2.0B |
EPS (Basic) | ₹190.95 | ₹164.25 | ₹105.80 | ₹95.28 | ₹71.00 |
EPS (Diluted) | ₹190.95 | ₹164.25 | ₹105.80 | ₹95.28 | ₹71.00 |
Basic Shares Outstanding | 10942000 | 10942000 | 10942000 | 10942548 | 10942000 |
Diluted Shares Outstanding | 10942000 | 10942000 | 10942000 | 10942548 | 10942000 |
Income Statement Trend
Kovai Medical Center Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 143.0M | 596.0M | 179.5M | 54.5M | 69.3M |
Short-term Investments | 2.6B | 1.5B | 2.3B | 1.9B | 1.5B |
Accounts Receivable | 237.7M | 125.2M | 167.2M | 161.0M | 105.4M |
Inventory | 156.2M | 147.0M | 137.2M | 125.8M | 102.3M |
Other Current Assets | 61.2M | 44.7M | 1.0K | 38.9M | 36.2M |
Total Current Assets | 3.3B | 2.5B | 3.0B | 2.4B | 1.9B |
Non-Current Assets | |||||
Property, Plant & Equipment | 12.8B | 11.2B | 10.9B | 10.8B | 10.3B |
Goodwill | 76.3M | 14.8M | 16.0M | 25.3M | 25.3M |
Intangible Assets | 76.3M | 14.8M | 16.0M | 25.3M | 25.3M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | -1.0K | 160.7M | -1.0K | -1.0K | -1.0K |
Total Non-Current Assets | 14.7B | 11.9B | 11.4B | 11.0B | 10.9B |
Total Assets | 18.0B | 14.4B | 14.4B | 13.4B | 12.8B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 294.9M | 263.9M | 273.3M | 142.2M | 154.6M |
Short-term Debt | 364.7M | 238.3M | 278.3M | 296.0M | 334.9M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 2.0K | 599.6M | 724.0M | 53.3M | 1.0K |
Total Current Liabilities | 2.7B | 2.0B | 1.8B | 1.6B | 1.4B |
Non-Current Liabilities | |||||
Long-term Debt | 3.8B | 2.9B | 4.8B | 5.2B | 5.9B |
Deferred Tax Liabilities | 387.4M | 378.9M | 355.1M | 339.8M | 331.0M |
Other Non-Current Liabilities | 693.0K | 409.0K | 696.0K | 5.3M | 3.8M |
Total Non-Current Liabilities | 4.4B | 3.5B | 5.4B | 5.7B | 6.3B |
Total Liabilities | 7.1B | 5.5B | 7.2B | 7.3B | 7.7B |
Equity | |||||
Common Stock | 109.4M | 109.4M | 109.4M | 109.4M | 109.4M |
Retained Earnings | 10.3B | 8.3B | 6.7B | 5.6B | 4.5B |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 10.9B | 8.9B | 7.2B | 6.1B | 5.1B |
Key Metrics | |||||
Total Debt | 4.2B | 3.1B | 5.1B | 5.5B | 6.2B |
Working Capital | 606.6M | 458.7M | 1.1B | 751.0M | 494.5M |
Balance Sheet Composition
Kovai Medical Center Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 2.8B | 2.4B | 1.6B | 1.4B | 1.1B |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | - | - |
Working Capital Changes | 63.6M | 407.0M | 156.5M | 302.7M | 38.5M |
Operating Cash Flow | 3.2B | 3.1B | 2.1B | 2.1B | 1.4B |
Investing Activities | |||||
Capital Expenditures | -3.5B | -1.4B | -1.3B | -991.0M | -1.8B |
Acquisitions | - | - | - | - | - |
Investment Purchases | - | 0 | -253.0K | 0 | - |
Investment Sales | 253.0K | - | - | - | - |
Investing Cash Flow | -3.5B | -1.4B | -1.3B | -991.0M | -1.8B |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | -107.4M | -109.0M | -65.8M | -32.8M | -1.7M |
Debt Issuance | - | - | - | - | - |
Debt Repayment | - | -2.0B | -283.2M | -730.6M | 651.2M |
Financing Cash Flow | -107.4M | -2.1B | -448.8M | -750.6M | 699.7M |
Free Cash Flow | -1.8M | 2.1B | 1.4B | 1.6B | 48.2M |
Net Change in Cash | -468.0M | -385.1M | 394.0M | 398.9M | 297.7M |
Cash Flow Trend
Kovai Medical Center Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
31.13
Forward P/E
94.87
Price to Book
6.32
Price to Sales
4.80
PEG Ratio
1.24
Profitability Ratios
Profit Margin
15.42%
Operating Margin
21.36%
Return on Equity
19.24%
Return on Assets
11.61%
Financial Health
Current Ratio
1.22
Debt to Equity
38.24
Beta
0.84
Per Share Data
EPS (TTM)
₹201.61
Book Value per Share
₹992.63
Revenue per Share
₹1,306.87
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
kovai | 68.4B | 31.13 | 6.32 | 19.24% | 15.42% | 38.24 |
Max Healthcare | 1.1T | 90.92 | 11.08 | 11.47% | 15.27% | 32.09 |
Apollo Hospitals | 1.1T | 68.03 | 13.04 | 16.71% | 6.98% | 90.89 |
Rainbow Children's | 135.1B | 53.76 | 9.37 | 16.50% | 16.73% | 51.77 |
Jupiter Life Line | 99.5B | 50.50 | 7.17 | 14.27% | 14.60% | 28.99 |
Healthcare Global | 91.9B | 243.94 | 9.70 | 4.49% | 1.61% | 185.57 |
Financial data is updated regularly. All figures are in the company's reporting currency.